MetLife Investment Advisors »

Phathom Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $150k 17k 9.13
2023-09-30 $171k 17k 10.37
2023-06-30 $176k 12k 14.32
2023-03-31 $88k 12k 7.14
2022-12-31 $138k 12k 11.22
2022-09-30 $136k 12k 11.08
2022-06-30 $104k 12k 8.45
2022-03-31 $167k 12k 13.58
2021-12-31 $153k 7.8k 19.67
2021-09-30 $249k 7.8k 32.10
2021-06-30 $263k 7.8k 33.85
2021-03-31 $191k 5.1k 37.56
2020-12-31 $169k 5.1k 33.22
2020-09-30 $187k 5.1k 36.75
2020-06-30 $167k 5.1k 32.82
2020-03-31 $131k 5.1k 25.75